跳至主要内容
临床试验/NCT05340127
NCT05340127Unknown不适用

Summative Usability Study of a Novel Device - CEREBO® for Non Invasive Detection of Intracranial Haemorrhage

Bioscan Research Pvt. Ltd.0 个研究点目标入组 10 人开始时间: 2022年4月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
10
主要终点
To assess the usability of CEREBO® to detect intracranial haemorrhage

研究概览

简要总结

Traumatic brain injury is one of the most common reasons for visits to the Emergency Department. More than 90% of patients who have suffered from head trauma present with a mild traumatic brain injury. Most of these patients do not present any symptom at the time of diagnosis thus delaying the detection. CEREBO®, a non-invasive, portable, rapid, point-of-care intracranial haemorrhage detector can avoid delayed detection by decreasing the time from injury to the initial CT scan. The study aims at assessing the summative usability of the device by determining its ease of use, ease of learning and satisfaction among the medical health professionals. The participants will be trained before the study and will be assessed periodically. Each participant will use the device on at least 10 subjects.

详细描述

A prospective interventional study designed to assess the summative usability and rapidity of CEREBO® - a portable device to detect intracranial haemorrhage. 10 participants from a Primary Health Centre will be enrolled in this study. The participants will be trained by the study staff before the study. The participant will fill in a questionnaire periodically. At the end of the study, the statistical analysis will be performed on the recorded data to establish the ease of use, ease of learning and satisfaction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Medical health professionals >18 years of age with a valid medical license to practice medicine belonging to one of the following categories and have given a written consent to participate in the study.
  • Of all ages and gender, have understood the study and gave a written informed consent.

排除标准

  • Cognitively impaired subjects unable to understand the study procedure

结局指标

主要结局

To assess the usability of CEREBO® to detect intracranial haemorrhage

时间窗: 2 week

A questionnaire filled by the participants will be assessed by the study team to assess the ease of use, ease of learning and satisfaction

次要结局

  • To assess the rapidity of CEREBO® to detect intracranial haemorrhage(2 week)

研究者

发起方
Bioscan Research Pvt. Ltd.
申办方类型
Industry
责任方
Sponsor

相似试验